Reaxbio
2 known investors
Find your way into Reaxbio
83 people in our graph share verified history with the Reaxbio team — schools, employers, funds. One of them is your warm intro.
Sarika Temme-Bapatunlockedknows Jeff Montgomery · together at University of Chicago (overlapped)
×10knows the team · via University of Chicago
knows the team · via Authorea
Reaxbio develops a chemoproteomics platform that identifies and targets novel protein sites for drug discovery across disease-relevant biological contexts. The platform enables small molecule discovery for virtually any protein using proprietary chemical tools and high-throughput screening capabilities.
Founders & leadership
JM
Jeff MontgomeryinCo-Founder & Principal ScientistJeff Montgomery is a chemical biologist with expertise in peptides, proteins, and assay development. He founded Reaxbio, which develops chemoproteomics platforms for drug discovery.
Investors · 2
Frequently asked questions
- What does Reaxbio do?
- Reaxbio develops a chemoproteomics platform that identifies and targets novel protein sites for drug discovery across disease-relevant biological contexts. The platform enables small molecule discovery for virtually any protein using proprietary chemical tools and high-throughput screening capabilities.
- Who founded Reaxbio?
- Reaxbio was founded by Jeff Montgomery.
- Who are Reaxbio's investors?
- Reaxbio's investors include OMX Ventures, Portal Innovations.